Cannell & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$9.43M	Sell	10,742 -175	-2%	-$144K	0.3%	77
2023 Q3	$8.98M	Sell	10,917 -10	-0.1%	-$7.86K	0.31%	81
2023 Q2	$7.85M	Buy	10,927 +80	+0.7%	+$61.7K	0.26%	92
2023 Q1	$8.91M	Sell	10,847 -1,431	-12%	-$1.08M	0.32%	84
2022 Q4	$8.86M	Buy	12,278 +23	+0.2%	+$17K	0.32%	82
2022 Q3	$8.44M	Sell	12,255 -33	-0.3%	-$20.8K	0.32%	81
2022 Q2	$7.26M	Sell	12,288 -202	-2%	-$131K	0.26%	91
2022 Q1	$8.72M	Sell	12,490 -65	-0.5%	-$41.1K	0.26%	94
2021 Q4	$7.93M	Sell	12,555 -535	-4%	-$329K	0.22%	98
2021 Q3	$7.92M	Buy	13,090 +89	+0.7%	+$55.3K	0.24%	98
2021 Q2	$7.26M	Sell	13,001 -5	-0%	-$2.53K	0.22%	101
2021 Q1	$6.15M	Sell	13,006 -9,700	-43%	-$4.72M	0.19%	108
2020 Q4	$11M	Buy	22,706 +9,461	+71%	+$5.11M	0.36%	76
2020 Q3	$7.41M	Buy	13,245 +299	+2%	+$181K	0.27%	86
2020 Q2	$8.07M	Sell	12,946 -22,276	-63%	-$12.6M	0.32%	72
2020 Q1	$17.2M	Sell	35,222 -431	-1%	-$178K	0.83%	40
2019 Q4	$13.7M	Buy	35,653 +23,857	+202%	+$8.03M	0.49%	69
2019 Q3	$3.27M	Sell	11,796 -4,985	-30%	-$1.48M	0.12%	118
2019 Q2	$5.25M	Sell	16,781 -21,177	-56%	-$7.05M	0.2%	102
2019 Q1	$15.6M	Sell	37,958 -6,869	-15%	-$2.83M	0.6%	62
2018 Q4	$16.7M	Sell	44,827 -1,036	-2%	-$379K	0.73%	47
2018 Q3	$18.5M	Buy	45,863 +13,147	+40%	+$5M	0.66%	54
2018 Q2	$11.3M	Buy	32,716 +31,736	+3,238%	+$9.93M	0.42%	69
2018 Q1	$337K	Buy	+980	New	+$341K	0.01%	213